Clinical impact of programmed cell death ligand 1 expression in colorectal cancer-Reference-Cited by-同舟云学术

Clinical impact of programmed cell death ligand 1 expression in colorectal cancer

Published:2013-06 Issue:9 Volume:49 Page:2233-2242
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Droeser Raoul A.,Hirt Christian,Viehl Carsten T.,Frey Daniel M.,Nebiker Christian,Huber Xaver,Zlobec Inti,Eppenberger-Castori Serenella,Tzankov Alexander,Rosso Raffaele,Zuber Markus,Muraro Manuele Giuseppe,Amicarella Francesca,Cremonesi Eleonora,Heberer Michael,Iezzi Giandomenica,Lugli Alessandro,Terracciano Luigi,Sconocchia Giuseppe,Oertli Daniel,Spagnoli Giulio C.,Tornillo Luigi

Funder

Swiss National Fund for scientific research (SNF)

Italian Association for Cancer Research (AIRC) IG

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome;Galon;Science,2006

2. Effector memory T cells, early metastasis, and survival in colorectal cancer;Pages;N Engl J Med,2005

3. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity;Khoury;Immunity,2004

4. The PD-1–PD-L pathway in immunological tolerance;Okazaki;Trends Immunol,2006

5. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity;Curiel;Nat Med,2003

Cited by 379 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive study on the prognostic value and clinicopathological significance of different immune checkpoints in patients with colorectal cancer: a systematic review and meta-analysis;Current Therapeutic Research;2024-09

2. The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types;BMC Cancer;2024-08-26

3. Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial;Clinical Cancer Research;2024-03-19

4. Prognostic and predictive role of immune microenvironment in colorectal cancer;World Journal of Gastrointestinal Oncology;2024-03-15

5. Immunotherapy and radiotherapy for older patients with locally advanced rectal cancer unfit for surgery or decline surgery: a practical proposal by the International Geriatric Radiotherapy Group;Frontiers in Oncology;2024-02-22